ClinicalTrials.Veeva

Menu

Using Wearable Device to Improve Quality of Palliative Care

National Taiwan University logo

National Taiwan University

Status

Enrolling

Conditions

End Stage Cancer
Terminal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05054907
202105097RIND

Details and patient eligibility

About

This study is going to use wearable devices and smartphones to collect physical data from terminal patients and build a survival predicting model for terminal patients with machine learning. Investigators hypothesize that continuous physical data monitoring could offer a hint to better predictability in end-of-life care.

Full description

The study aim to examine the feasibility of utilizing wearable devices and smartphones in palliative patients in Taiwan. In addition, investigators try to identify the relationship between mobile health data and disease progression and establish a predicting model to the emergent medical need and death of patients, via machine learning.

This is a single-arm observational study using wearable devices and smartphones in terminal cancer patients. Investigators planned to enroll 75 patients who receive palliative care. After obtaining consent from the patients or their legally authorized surrogate decision-makers, a baseline assessment will be conducted, with a guide to use wearable devices and phone apps.

Investigators will keep regular follow-up for 52 weeks or until the participants' death. Assessment will be conducted every week, face-to-face or by telephone contact. A routine assessment includes symptoms and functionality in the past week, and vital signs and facial photograph will be recorded if possible. Physical data measured from wearable devices would be recorded continuously. The emergent medical needs of patient, including emergency department visit, unplanned admission and death of participants will be recorded if happen.

The primary outcome is the predictive performance (sensitivity and specificity) of the machine-learning model using wearable device data and symptoms assessment. The secondary outcomes are symptoms, including pain, dyspnea, diarrhea, constipation, nausea, vomiting, insomnia, depression, anxiety and fatigue. Users' opinion and comment to using experience will also be recorded.

Enrollment

75 estimated patients

Sex

All

Ages

20 to 105 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

  • Age: 20 years old or older
  • Clinical diagnosis: cancer in terminal stage.

Exclusion criteria

  • Cannot cooperate with use of wearable devices or smartphones.

Trial design

75 participants in 1 patient group

Wearable devices + Smartphone
Description:
The only arm in the study.

Trial contacts and locations

2

Loading...

Central trial contact

Jen-Hsuan Liu, MD; Jaw-Shiun Tsai, MDPHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems